InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: RockoTaco post# 96183

Tuesday, 09/17/2019 4:02:21 PM

Tuesday, September 17, 2019 4:02:21 PM

Post# of 140477
I thought Trixie HAD a single port offering which the FDA shot down... they just missed the boat on the "then new" Human Factors Engineering guidelines, had insufficient redundancies, and insufficient IP portfolio to back it up if challenged, so they scrapped the project or sold it for peanuts. Maybe it is now the deli slicer that 2014 keeps harping about.

Anyway, as I understood it, Titan was slicing chicken in a bottle with a rudimentary system which needed much further development; meanwhile Trixie went to the FDA with their similar-state (rudimentary) offering (Surgibot) and got laughed at. Titan kept at it, securing patent after patent on ever-improving technology while nailing down all the requirements for a world-class medical instrument. The fact that Trixie didn't pursue their single-port device implies to me that maybe they knew they couldn't secure the patents needed because the competition (Titan and ISRG) had already locked everything down legally. This also raises the question as to who else can get into the single port space, given the IP that is already spoken for.

Now... can anyone point to Medtronics' vast IP holdings for single port? Or does it not exist? Just curious... I may have to raise my odds to 25% chance for that partnership!


Message in reply to:
Is TRXC still around? I remember when that was trading at $14/share, had a $1B market cap - man, people really got screwed on that but hey they put out a lot of PR's and really pumped up that company every chance they got. They always got money (then lost it)......just can't make up for a poor product. If they had a novel, next generation surgical robotic platform would have been very helpful. AND if they had SINGLE PORT on top of that, well they would have went from $14 to $40 a share and had over a $3B MC by now.


We hold Titan b/c they are moving forward and have milestones on the near horizon that will increase value exponentially. TRXC has none, it is already an FDA approved product in the market place and it has fallen to where it currently sits.......no holding onto that stock hoping it rebounds, how can it.